Depomed (DEPO) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. RCKT
6. CRBU
7. SKYD
8. BBIO
9. CRWV
10. OPCH

Go back to Depomed (DEPO) Tops Q2 EPS by 2c

Depomed Reports Second Quarter 2016 Financial Results

August 3, 2016 4:01 PM EDT

- Second Quarter Revenues of $117 million, 23% over 2Q 2015 -- NUCYNTA® Franchise Second Quarter 2016 Record Net Sales of $72 million, 27% over 2Q 2015 -- Conference Call Scheduled for Today at 4:30 PM EDT; Dial In Information Below -

NEWARK, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq: DEPO) today reported financial results and highlighted operational achievements for the quarter ended June 30, 2016.

"The second quarter marked the 1-year anniversary of the mid-June relaunch of our flagship NUCYNTA franchise, said Jim Schoeneck, President and CEO of Depomed. During the first full year after our relaunch, we delivered... More